Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (21-30 of 576) with videos related to

Pageof 58
Sort By:
The Journal of Biological Chemistry|June 25, 1993
Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain functionA Sauter, M Rudin
Stroke|November 1, 1986
Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imagingA Sauter, M Rudin
Magnetic Resonance Imaging|January 1, 1992
In vivo NMR in pharmaceutical researchM Rudin, A Sauter
Oncology (Williston Park, N.Y.)|September 6, 2011
ALK-targeted therapy for lung cancer: ready for prime timeHatim Husain, Charles M Rudin
The New England Journal of Medicine|October 1, 2025
Tarlatamab in Small-Cell Lung Cancer. ReplyCharles M Rudin, Giannis Mountzios
Translational Lung Cancer Research|January 5, 2018
Small-cell lung cancer in the era of immunotherapyMargarita Majem, Charles M Rudin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Tarlatamab: New Star on the Horizon for Small-Cell Lung Cancer?Salomon Tendler, Charles M Rudin
Molecular and Cellular Biology|January 1, 1992
Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factorsC M Rudin, U Storb
Current Problems in Cancer|April 13, 2012
Novel therapeutic approaches for small cell lung cancer: the future has arrivedMaria Catherine Pietanza, Charles M Rudin
Cell Reports. Medicine|October 8, 2021
Co-targeting TGF-β and PD-L1 with radiation therapy: The Goldilocks principleSamuel F Bakhoum, Charles M Rudin
Pageof 58

Showing results (21-30 of 576) with videos related to

Sort By:
Pageof 58
The Journal of Biological Chemistry|June 25, 1993
Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain functionA Sauter, M Rudin
Stroke|November 1, 1986
Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imagingA Sauter, M Rudin
Magnetic Resonance Imaging|January 1, 1992
In vivo NMR in pharmaceutical researchM Rudin, A Sauter
Oncology (Williston Park, N.Y.)|September 6, 2011
ALK-targeted therapy for lung cancer: ready for prime timeHatim Husain, Charles M Rudin
The New England Journal of Medicine|October 1, 2025
Tarlatamab in Small-Cell Lung Cancer. ReplyCharles M Rudin, Giannis Mountzios
Translational Lung Cancer Research|January 5, 2018
Small-cell lung cancer in the era of immunotherapyMargarita Majem, Charles M Rudin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Tarlatamab: New Star on the Horizon for Small-Cell Lung Cancer?Salomon Tendler, Charles M Rudin
Molecular and Cellular Biology|January 1, 1992
Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factorsC M Rudin, U Storb
Current Problems in Cancer|April 13, 2012
Novel therapeutic approaches for small cell lung cancer: the future has arrivedMaria Catherine Pietanza, Charles M Rudin
Cell Reports. Medicine|October 8, 2021
Co-targeting TGF-β and PD-L1 with radiation therapy: The Goldilocks principleSamuel F Bakhoum, Charles M Rudin
Pageof 58